Lawmakers urge FDA to enact new China policies after 3 gene therapy deaths

RegulatoryNegative

AI Analysis

Summary

Two U.S. lawmakers have called on the FDA to establish new policies to protect American patients following three deaths in gene therapy clinical trials conducted in China.

Outcome Details

Lawmakers urge FDA to enact new policies following gene therapy deaths in China clinical trials

Importance:4/10

Sentiment:

-0.80

FDAgene therapysafety concernsregulatory policyclinical trial deathsChina

Read the original article

Published by BioSpace on August 21, 2026 2:37 PM

Read Original